Table 3. Average weekly FLS prevalence in patients divided based on the IL-6 genotypes or on the presence of the C allele.
week | G/G | C/G | C/C | C/C+C/G |
---|---|---|---|---|
(n = 82) | (n = 54) | (n = 11) | (n = 65) | |
1 | 0.72 | 0.64 | 0.40 | 0.60 |
2 | 0.61 | 0.51 | 0.40 | 0.49 |
3 | 0.63 | 0.40 | 0.30 | 0.38 |
4 | 0.49 | 0.31 | 0.36 | 0.32 |
5 | 0.48 | 0.27 | 0.30 | 0.27 |
6 | 0.45 | 0.27 | 0.30 | 0.27 |
7 | 0.38 | 0.34 | 0.36 | 0.34 |
8 | 0.35 | 0.31 | 0.18 | 0.29 |
9 | 0.42 | 0.25 | 0.27 | 0.25 |
10 | 0.39 | 0.31 | 0.36 | 0.32 |
11 | 0.34 | 0.31 | 0.36 | 0.32 |
12 | 0.32 | 0.24 | 0.18 | 0.23 |